Blog
RSS FeedPosted by Michael Wonder on 01 Apr 2022
Price slashed for revolutionary $78,000 a year prostate cancer treatment Lynparza
1 April 2022 - A new subsidy for a revolutionary drug is set to benefit thousands of Aussie men with aggressive ...
Posted by Michael Wonder on 01 Apr 2022
Making medicines more affordable for more Australians
1 April 2022 - Australians will have cheaper access to treatments for high cholesterol, heart failure and high blood pressure from ...
Posted by Michael Wonder on 01 Apr 2022
Public Summary Documents – December 2021 PBAC meeting
1 April 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2021 PBAC ...
Posted by Michael Wonder on 31 Mar 2022
Agenda for July 2022 PBAC meeting
1 April 2022 - 30 March 2022 - The agenda for the July 2022 PBAC meeting is now available. ...
Posted by Michael Wonder on 31 Mar 2022
Schedule of Pharmaceutical Benefits - 1 April 2022
1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Mar 2022
2022 April cycle - brand price reductions and savings to patients
31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...
Posted by Michael Wonder on 30 Mar 2022
Government hopes to hook voters with cheaper drugs
29 March 2022 - Patients will get access to cheaper or free medicines sooner under plans to reduce the PBS ...
Posted by Michael Wonder on 29 Mar 2022
Federal budget 2022: more funding for breast cancer drug Trodelvy
29 March 2022 - Against all the odds Sydney mum Alison Day will get to celebrate her daughter’s 12th birthday — ...
Posted by Michael Wonder on 29 Mar 2022
Government fails to adequately address medicine affordability for working Australians
29 March 2022 - The cost of medicines will continue to go up unchecked as the Federal Government has failed ...
Posted by Michael Wonder on 28 Mar 2022
Federal Budget vision must extend beyond election day to secure better long-term health for all Australians
28 March 2022 - Medicines Australia is hoping tomorrow’s Budget reveals a long-term vision for health with strong investments in ...
Posted by Michael Wonder on 26 Mar 2022
Landmark PBS listing for Australians with cystic fibrosis
27 March 2022 - From April 1 2022, Trikafta (elexacaftor with tezacaftor and ivacaftor and ivacaftor) will be available on ...
Posted by Michael Wonder on 25 Mar 2022
Expanded PBS listing for lung disease medication
25 March 2022 - The Australian Government is helping more Australians access the medications they need with a new addition to ...
Posted by Michael Wonder on 23 Mar 2022
Government opts for additional consultation on National Medicines Policy review
24 March 2022 - The Government has heeded the calls from Medicines Australia, patient groups, health bodies, and industry by ...
Posted by Michael Wonder on 21 Mar 2022
DoH publishes revised agenda for this month's PBAC meeting
21 March 2022 - This is the first time we can recall that the DoH has published a revised agenda ...
Posted by Michael Wonder on 21 Mar 2022
Mum’s fear as promising cancer drug out of reach
21 March 2022 - A terminally ill mum desperate for “more time” with her family was “broken” when she learnt the ...